Novel homogeneous liposomal immunoassay for colorimetric estimation of serum IgG anticardiolipin antibodies

Clinical Chemistry

Volumn 42, Issue 6 SUPPL., 1996, Pages 874-879

  Frost, Stephen J ^a,b   Chakraborty, Jessie ^b   Firth, Gary B ^a  

^a PRINCESS ROYAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Liposomes; Spectrophotometry; Sulforhodamine B

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; LIPOSOME;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL;

ANTIBODIES, ANTICARDIOLIPIN; COLORIMETRY; COLORING AGENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; LIPOSOMES; REFERENCE VALUES; RHODAMINES; SENSITIVITY AND SPECIFICITY;

EID: 0029941123     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.6.874     Document Type: Article

References (30)

1. Braman JC, Broeze RJ, Bowden DW, Myles A, Fulton TR, Risling M, et al. Enzyme membrane immunoassay (EMIA). Biotechnology 1984;2:349-55.
2. Ligler FS, Bredehorst R, Talebian A, Shriver LC, Hammer CF, Sheriden JP, et al. A homogeneous immunoassay for mycotoxin T-2 utilizing liposomes, monoclonal antibodies and complement. Anal Biochem 1987;163:369-75.
3. Umeda M, Ishimori Y, Yoshikawa K, Takada M, Tatsuji Y. Liposome immune lysis (LILA). J Immunol Methods 1986;95:15-21.
4. Frost SJ, Firth GB, Chakraborty J. A novel colourimetric liposomal immunoassay using sulphorhodamine-B. J Liposome Res 1994; 4:1159-82.
5. Freytag JW, Litchfield WJ. Liposome-mediated immunoassays for small haptens (digoxin) independent of complement. J Immunol Methods 1984;70:133-40.
6. Litchfield WJ, Freytag JW, Adamich M. Highly sensitive immunoassays based on the use of liposomes without complement. Clin Chem 1984;30:1441-5.
7. Janoff AS, Carpenter-Green S, Weiner AL, Seibond J, Weissmann G, Ostro J. Novel liposome composition for a rapid colorimetric test for systemic lupus erythematosus. Clin Chem 1983;29: 1587-92.
8. Rand RP, Sengupta S. Cardiolipin forms hexagonal structures with divalent cations. Biochim Biophys Acta 1972;255:484-92.
9. Harris EN, Gharavi AE, Boey ML, Patel BM, Makworth-Young CG, Loizou S, Hughes GRV. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983;ii:1211-4.
10. Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987;68:215-22.
11. Harris EN. Antiphospholipid antibodies. Br J Haematol 1990;74: 1-9.
12. Makworth-Young CG, Loizou S, Walport MJ. Antiphospholipid antibodies and disease. Q J Med 1989;269:767-77.
13. Makworth-Young C. Antiphospholipid antibodies: more than just a disease marker? Immunol Today 1990;11:60-5.
14. Szoka F, Papahadjopoulos D. Procedure for preparation of liposomes with large internal space and high capture by reversephase evaporation. Proc Natl Acad Sci U S A 1978;75:4194-8.
15. Frost SJ, Firth GB, Chakraborty J. Antibody-coated liposomes as a particulate solid phase for immunoassays: measurement of urinary 'micro-albumin'. J Immunol Methods 1990;134:207-13.
16. Nomura Y, Imai K, Suzuki M, Okuda K. Development of a liposome-based colorimetric immunoassay of serum thyroxin. Clin Chem 1987;33:1565-6.
17. Galli M, Comfurius P, Maasen C, Hemker HC, De Baets MH, Van Breda-Vriesman PJC, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;1:1544-7.
18. 2 glycoprotein I as an antigen. J Immunol Methods 1991;143:223-9.
19. Harris EN, Pierangeli S, Barquinero S, Ordi-Ros J. Anticardiolipin antibodies and binding of anionic phospholipids and serum protein. Lancet 1990;ii:505-6.
20. Galli M, Barbui T, Bevers EM, Comfurius P, Zwaal RFA. The plasma cofactor and anticardiolipin antibodies; authors reply [Letter]. Clin Exp Rheumatol 1990;8:614-5.
21. 2-glycoprotein I? J Clin Lab Med 1993;122:426-31.
22. Harris EN, Pierangeli SS. Anticardiolipin and lupus anticoagulant testing and significance. J Clin Immunoassay 1994;17:109-17.
23. Reber G, Tremblet C, Bernard C, Mermillod B, de Moerloose P. Anticardiolipin antibodies and thrombosis: buffer's influence on the detection and quantitation of anticardiolipin antibody measured by ELISA. Thromb Res 1990;57:215-26.
24. Cheng H-M, Ngeow Y-F, Sam C-K. Heat inactivation of serum potentiates anti-cardiolipin antibody binding in ELISA. J Immunol Methods 1989;124:235-8.
25. Harris EN, Hughes GRV. Standardising the anti-cardiolipin antibody test [Letter]. Lancet 1987;i:277.
26. Harris EN. The second international anti-cardiolipin standardization workshop/the Kingston anti-phospholipid antibody study (KAPS) group. Am J Clin Pathol 1990;94:476-84.
27. Hamsten A, Norberg R, Bjorkholm M, De Faire U, Holm G. Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet 1986;i:113-5.
28. Sletnes KE, Larson EW, Stokland O, Wisloff F. Antiphospholipid antibodies detected as anti-cephalin and anti-cardiolipin antibodies in patients with acute myocardial infarction. Thromb Res 1990;59:675-80.
29. Raghavan C, Ditchfield J, Taylor RJ, Haeney MR, Barnes PC. Influence of anticardiolipin antibodies on immediate patient outcome after myocardial infarction. J Clin Pathol 1993;46:1113-5.
30. Phadke KV, Phillips RA, Clarke DTR, Jones M, Naish P, Carson P. Anticardiolipin antibodies in ischaemic heart disease: marker or myth. Br Heart J 1993;69:391-4.